VIR
Vir Biotechnology Inc.
$10.00
-$0.21(-2.10%)
56
Overall
60
Value
63
Tech
47
Quality
Market Cap
$720.67M
Volume
1.05M
52W Range
$4.16 - $11.66
Target Price
$20.78
Company Overview
| Mkt Cap | $720.67M | Price | $10.00 |
| Volume | 1.05M | Change | -2.10% |
| P/E Ratio | -1.4 | Open | $10.22 |
| Revenue | $74.2M | Prev Close | $10.22 |
| Net Income | $-522.0M | 52W Range | $4.16 - $11.66 |
| Div Yield | N/A | Target | $20.78 |
| Overall | 56 | Value | 60 |
| Quality | 47 | Technical | 63 |
No chart data available
Latest News
Vidrala (0NV7) Receives a Buy from UBS
TipRanks Auto-Generated Intelligence Newsdesk•2 days ago
Analysts Are Bullish on Top Healthcare Stocks: Agios Pharma (AGIO), Atea Pharmaceuticals (AVIR)
Brian Anderson•2 days ago
Vir Biotechnology Marks Key Hepatitis B Milestone With Phase 2 Combo Study Update
TipRanks Clinical-Trials-Auto-Generated Newsdesk•8 days ago
Vidrala (0NV7) Gets a Hold from Citi
TipRanks Auto-Generated Intelligence Newsdesk•9 days ago
Virbac SA (0NM7) Receives a Buy from Kepler Capital
TipRanks Auto-Generated Intelligence Newsdesk•13 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VIR | $10.00 | -2.1% | 1.05M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |